Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

Treatment decisions after diagnosis of clinically localised prostate cancer are difficult due to variability in tumour behaviour. We therefore examined one of the most promising biomarkers in prostate cancer, Ki-67, in a cohort of 808 patients diagnosed with prostate cancer between 1990 and 1996 and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2009-03, Vol.100 (6), p.888-893
Hauptverfasser:	Berney, D M, Gopalan, A, Kudahetti, S, Fisher, G, Ambroisine, L, Foster, C S, Reuter, V, Eastham, J, Moller, H, Kattan, M W, Gerald, W, Cooper, C, Scardino, P, Cuzick, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antigens Biological and medical sciences Biomarkers Biomedical and Life Sciences Biomedicine Biopsy Cancer Research Cancer therapies Cell cycle Clinical Study Drug Resistance Epidemiology Humans Immunohistochemistry Ki-67 Antigen - analysis Laboratories Lymphatic system Male Medical prognosis Medical research Medical sciences Metastasis Middle Aged Molecular Medicine Nephrology. Urinary tract diseases Oncology Pathology Patients Preventive medicine Prognosis Prostate cancer Prostatic Neoplasms - diagnosis Prostatic Neoplasms - mortality Prostatic Neoplasms - pathology Prostatic Neoplasms - therapy Surveillance Tumors Tumors of the urinary system Urinary tract. Prostate gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!